---
title: "Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294363759.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-30T09:41:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294363759.md)
  - [en](https://longbridge.com/en/news/294363759.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294363759.md)
---

# Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [Abner Herrman & Brock LLC Decreases Stock Holdings in Amgen Inc. $AMGN](https://longbridge.com/en/news/295293655.md)
- [Amgen Inc. $AMGN Shares Sold by NewEdge Advisors LLC](https://longbridge.com/en/news/295208107.md)
- [Immunology specialist Khartis Therapeutics emerges from stealth with $95m](https://longbridge.com/en/news/295919132.md)
- [SCRI and MSD to broaden US oncology trial access](https://longbridge.com/en/news/295984760.md)
- [United global response to US childhood vaccine overhaul](https://longbridge.com/en/news/295823083.md)